West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
314.50
-2.82 (-0.89%)
Jun 5, 2026, 4:00 PM EDT - Market closed
Hatton National Bank Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 22,219 | 19,810 | 23,683 | 25,881 | 17,439 | 34,801 | |
Market Cap Growth | 48.01% | -16.35% | -8.49% | 48.40% | -49.89% | 65.99% |
Enterprise Value | 22,018 | 19,317 | 23,482 | 25,318 | 16,847 | 34,354 |
Last Close Price | 314.50 | 275.14 | 327.56 | 352.12 | 235.35 | 469.01 |
PE Ratio | 42.03 | 40.52 | 48.96 | 44.69 | 30.45 | 54.10 |
Forward PE | 36.10 | 36.69 | 45.90 | 42.23 | 34.84 | 53.55 |
PEG Ratio | 2.71 | 3.06 | 5.25 | 5.39 | 2.31 | 2.37 |
PS Ratio | 6.90 | 6.44 | 8.19 | 8.77 | 6.04 | 12.29 |
PB Ratio | 7.46 | 6.24 | 8.83 | 8.98 | 6.50 | 14.90 |
P/TBV Ratio | 7.63 | 6.30 | 9.00 | 9.20 | 6.64 | 15.32 |
P/FCF Ratio | 48.51 | 42.25 | 85.68 | 62.44 | 39.69 | 105.27 |
P/OCF Ratio | 31.06 | 26.25 | 36.25 | 33.33 | 24.09 | 59.59 |
EV/Sales Ratio | 6.84 | 6.28 | 8.12 | 8.58 | 5.84 | 12.13 |
EV/EBITDA Ratio | 25.31 | 25.54 | 32.38 | 31.13 | 19.71 | 39.28 |
EV/EBIT Ratio | 31.76 | 33.03 | 41.20 | 37.45 | 22.95 | 45.67 |
EV/FCF Ratio | 48.07 | 41.20 | 84.96 | 61.08 | 38.34 | 103.91 |
Debt / Equity Ratio | 0.10 | 0.09 | 0.11 | 0.10 | 0.11 | 0.14 |
Debt / EBITDA Ratio | 0.38 | 0.43 | 0.42 | 0.38 | 0.37 | 0.37 |
Debt / FCF Ratio | 0.69 | 0.69 | 1.09 | 0.75 | 0.72 | 0.98 |
Net Debt / Equity Ratio | -0.07 | -0.15 | -0.07 | -0.19 | -0.21 | -0.19 |
Net Debt / EBITDA Ratio | -0.25 | -0.62 | -0.25 | -0.67 | -0.67 | -0.50 |
Net Debt / FCF Ratio | -0.45 | -1.00 | -0.66 | -1.31 | -1.31 | -1.32 |
Asset Turnover | 0.77 | 0.78 | 0.77 | 0.79 | 0.83 | 0.93 |
Inventory Turnover | 4.58 | 4.80 | 4.67 | 4.29 | 4.41 | 4.73 |
Quick Ratio | 1.79 | 2.09 | 1.88 | 2.03 | 2.70 | 2.11 |
Current Ratio | 2.71 | 3.02 | 2.79 | 2.88 | 3.70 | 2.93 |
Return on Equity (ROE) | 17.60% | 16.85% | 17.71% | 21.32% | 23.34% | 31.59% |
Return on Assets (ROA) | 12.34% | 11.79% | 12.45% | 14.98% | 17.61% | 21.11% |
Return on Invested Capital (ROIC) | 16.40% | 15.72% | 17.00% | 22.05% | 26.34% | 31.74% |
Return on Capital Employed (ROCE) | 18.58% | 17.44% | 18.23% | 21.61% | 25.23% | 30.03% |
Earnings Yield | 2.44% | 2.47% | 2.04% | 2.24% | 3.28% | 1.85% |
FCF Yield | 2.06% | 2.37% | 1.17% | 1.60% | 2.52% | 0.95% |
Dividend Yield | 0.28% | 0.31% | 0.25% | 0.22% | 0.31% | 0.15% |
Payout Ratio | 11.63% | 12.04% | 11.65% | 9.33% | 8.92% | 7.49% |
Buyback Yield / Dilution | 1.12% | 1.36% | 2.12% | 0.66% | 0.66% | -0.66% |
Total Shareholder Return | 1.40% | 1.66% | 2.37% | 0.88% | 0.96% | -0.51% |